Fulgent Genetics, Inc. (FLGT) vs Personalis, Inc. (PSNL)
- Fulgent Genetics, Inc. FLGT 19.81 −7.17%
- Personalis, Inc. PSNL 15.65 −1.76%
Fulgent Genetics, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $587.2M — 2.9× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 6.83% against −13.3%. Fulgent Genetics, Inc. has the higher net margin (−26.1% vs −153.8%) and the higher return on invested capital (−10.3% vs −317.5%). Across the 17 metrics below, Fulgent Genetics, Inc. leads on 12 and Personalis, Inc. on 5.
Valuation
Profitability
| Metric | FLGT | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 35.58% | 12.69% | 50.89% |
| Operating margin | (37.75%) | (164.07%) | (8.57%) |
| Net margin | (26.05%) | (153.84%) | (6.37%) |
| Free cash flow margin | (32.04%) | (144.76%) | 0.00% |
| Return on equity | (8.01%) | (50.32%) | (2.92%) |
| Return on assets | (7.37%) | (37.55%) | (6.71%) |
| Return on invested capital | (10.34%) | (317.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack